Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.71% is 70% below its 5-year average of 2.40%, near the low end of its 5-year range (0.71%–3.57%).
As of the fiscal period ended Tuesday, June 30, 2026. 52.68% below its 12-month average of 1.50%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.71%.
DEBT TO ASSETS RATIO
0.71%
DEBT TO ASSETS RATIO AVG TTM
1.50%
DEBT TO ASSETS RATIO AVG 3Y
1.83%
DEBT TO ASSETS RATIO AVG 5Y
2.40%
DEBT TO ASSETS RATIO AVG 10Y
2.14%
DEBT TO ASSETS RATIO AVG 15Y
1.44%
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-52.68%
CURRENT VS 3Y AVG
-61.28%
CURRENT VS 5Y AVG
-70.36%
CURRENT VS 10Y AVG
-66.88%
CURRENT VS 15Y AVG
-50.72%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+689.26%
vs the sector median at left
Assembly Biosciences, Inc.
Market Cap
$439.55M
Debt to Assets Ratio
0.71%
TTM Avg
1.50%
3Y Avg
1.83%
5Y Avg
2.40%
Market Cap
$438.07M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$442.34M
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$435.61M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$445.71M
Debt to Assets Ratio
0.25%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$426.51M
Debt to Assets Ratio
0.69%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Assembly Biosciences, Inc. (ASMB) | $439.55M | 0.71% | 1.50% | 1.83% | 2.40% |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $438.07M | 0.00% | N/A | N/A | N/A |
| Ovid Therapeutics Inc. (OVID)vs › | $442.34M | 0.05% | N/A | N/A | N/A |
| YD Bio Limited Ordinary Shares (YDES)vs › | $435.61M | 0.00% | N/A | N/A | N/A |
| Capricor Therapeutics, Inc. (CAPR)vs › | $445.71M | 0.25% | N/A | N/A | N/A |
| NeuroPace, Inc. (NPCE)vs › | $431.97M | 0.72% | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $452.54M | 0.66% | N/A | N/A | N/A |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $426.51M | 0.69% | N/A | N/A | N/A |
| NeoGenomics, Inc. (NEO)vs › | $424.10M | 0.33% | N/A | N/A | N/A |
| Tectonic Therapeutic, Inc. (TECX)vs › | $422.86M | 0.02% | N/A | N/A | N/A |
Debt/Assets
0.7%
Debt/Equity
0.01
Current Ratio
13.99
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.71% |
| 2026-03-31 | 1.06% |
| 2025-12-31 | 1.02% |
| 2025-09-30 | 1.15% |
| 2025-06-30 | 3.57% |
| 2025-03-31 | 3.05% |
| 2024-12-31 | 2.59% |
| 2024-09-30 | 1.44% |
| 2024-06-30 | 1.51% |
| 2024-03-31 | 1.61% |
| 2023-12-31 | 1.70% |
| 2023-09-30 | 1.78% |
| 2023-06-30 | 2.65% |
| 2023-03-31 | 3.16% |
| 2022-12-31 | 3.40% |
| 2022-09-30 | 3.53% |
| 2022-06-30 | 3.54% |
| 2022-03-31 | 3.51% |
| 2021-12-31 | 3.39% |
| 2021-09-30 | 2.91% |
| 2021-06-30 | 3.04% |
| 2021-03-31 | 3.08% |
| 2020-12-31 | 3.58% |
| 2020-09-30 | 3.52% |
| 2020-06-30 | 3.78% |
| 2020-03-31 | 3.77% |
| 2019-12-31 | 3.61% |
| 2019-09-30 | 5.84% |
| 2019-06-30 | 5.34% |
| 2019-03-31 | 5.10% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 9161143.01% |
| 2010-12-31 | 17.04% |
| 2010-09-30 | 1497.11% |
| 2010-06-30 | 924.31% |
| 2010-03-31 | 799.46% |
| 2009-12-31 | 5420.65% |
